[{"NetIncomeLoss_1_Q2_USD":-22910000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"GeneralAndAdministrativeExpense_2_Q2_USD":11513000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5842000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":51551844.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":51603286.0,"CommitmentsAndContingencies_0_Q2_USD":null,"PaidInKindInterest_2_Q2_USD":234000.0,"LiabilitiesNoncurrent_0_Q2_USD":24204000.0,"InterestPaidNet_2_Q2_USD":996000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":126548000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-7548000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":7000.0,"AssetsCurrent_0_Q2_USD":262555000.0,"DepositsAssetsCurrent_0_Q2_USD":6917000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":825000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":119000000.0,"CommonStockSharesIssued_0_Q2_shares":48616628.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":185091000.0,"Assets_0_Q2_USD":263059000.0,"ShareBasedCompensation_2_Q2_USD":6007000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":338000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":9727000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":8000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":21000.0,"Liabilities_0_Q2_USD":48496000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":833802000.0,"LongTermLoansPayable_0_Q2_USD":13323000.0,"ShortTermInvestments_0_Q2_USD":185091000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":38742000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":16871000.0,"LoansPayableCurrent_0_Q2_USD":7030000.0,"ProceedsFromStockPlans_2_Q2_USD":143000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-107000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-50000.0,"CommonStockValue_0_Q2_USD":5000.0,"Supplies_0_Q2_USD":22000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":6980000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"UnamortizedDebtIssuanceExpense_0_Q2_USD":137000.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":171000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":11724000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-50633000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-22910000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-50612000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-22902000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":116000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":68041000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":22000.0,"RestrictedCash_0_Q2_USD":115000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-758000.0,"InterestReceivableCurrent_0_Q2_USD":433000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"CommonStockSharesOutstanding_0_Q2_shares":48616628.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":2285000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":24000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3240000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-46634000.0,"LoansPayable_0_Q2_USD":20353000.0,"LiabilitiesCurrent_0_Q2_USD":24292000.0,"AccountsPayableCurrent_0_Q2_USD":3624000.0,"NonoperatingIncomeExpense_2_Q2_USD":-1136000.0,"NonoperatingIncomeExpense_1_Q2_USD":-576000.0,"InterestExpense_2_Q2_USD":1258000.0,"InterestExpense_1_Q2_USD":634000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":9308000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1706000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":292000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q2_USD":17000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":68156000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":191394.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":7988000.0,"PrepaidInsurance_0_Q2_USD":1531000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":166000.0,"NetIncomeLoss_2_Q2_USD":-50633000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-47202000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-619261000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-300000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":185074000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":758000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":379000.0,"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_1_Q2_USD":64000.0,"OperatingIncomeLoss_2_Q2_USD":-49497000.0,"OperatingIncomeLoss_1_Q2_USD":-22334000.0,"InvestmentIncomeInterest_2_Q2_USD":229000.0,"InvestmentIncomeInterest_1_Q2_USD":108000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":1517000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":263059000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2535000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2357000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3240000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":397000.0,"OperatingExpenses_2_Q2_USD":50255000.0,"OperatingExpenses_1_Q2_USD":22713000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":235000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.98,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.44,"ProfitLoss_2_Q2_USD":-50633000.0,"StockholdersEquity_0_Q2_USD":214563000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":10859000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":20000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6007000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":394000.0,"Ticker":"SNDX","CIK":"1395937","name":"SYNDAX PHARMACEUTICALS INC","OfficialName":"Syndax Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"934158860.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]